ATE373646T1 - Flavonoidverbindungen als therapeutische antioxidationsmittel - Google Patents

Flavonoidverbindungen als therapeutische antioxidationsmittel

Info

Publication number
ATE373646T1
ATE373646T1 AT03764001T AT03764001T ATE373646T1 AT E373646 T1 ATE373646 T1 AT E373646T1 AT 03764001 T AT03764001 T AT 03764001T AT 03764001 T AT03764001 T AT 03764001T AT E373646 T1 ATE373646 T1 AT E373646T1
Authority
AT
Austria
Prior art keywords
flavonoid compounds
compounds
antioxidants
therapeutic
therapeutic antioxidants
Prior art date
Application number
AT03764001T
Other languages
English (en)
Inventor
Stuart Caldwell
Christopher Bennett
Richard Hartley
Donald Mcphail
Garry Duthie
Original Assignee
Rowett Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowett Res Inst filed Critical Rowett Res Inst
Application granted granted Critical
Publication of ATE373646T1 publication Critical patent/ATE373646T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pyrane Compounds (AREA)
AT03764001T 2002-07-13 2003-07-14 Flavonoidverbindungen als therapeutische antioxidationsmittel ATE373646T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0216371.5A GB0216371D0 (en) 2002-07-13 2002-07-13 Compounds

Publications (1)

Publication Number Publication Date
ATE373646T1 true ATE373646T1 (de) 2007-10-15

Family

ID=9940455

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03764001T ATE373646T1 (de) 2002-07-13 2003-07-14 Flavonoidverbindungen als therapeutische antioxidationsmittel

Country Status (9)

Country Link
US (1) US7601754B2 (de)
EP (1) EP1534698B1 (de)
AT (1) ATE373646T1 (de)
AU (1) AU2003251328B2 (de)
CA (1) CA2492274C (de)
DE (1) DE60316447T2 (de)
ES (1) ES2294323T3 (de)
GB (1) GB0216371D0 (de)
WO (1) WO2004007475A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1837202B (zh) * 2006-04-25 2010-08-18 中国人民解放军第二军医大学 具有降血脂作用的黄酮醇类化合物
EP2086318A4 (de) * 2006-10-10 2009-12-23 Burnham Inst Medical Research Neuroprotektive zusammensetzungen und verfahren
GB0623174D0 (en) * 2006-11-21 2006-12-27 Univ Robert Gordon Compounds
CA2696753A1 (en) * 2007-08-17 2009-02-26 Herbalscience Group Llc Antiinfective flavononol compounds and methods of use thereof
GB0719751D0 (en) * 2007-10-10 2007-11-21 Antoxis Ltd In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
EP2112145A1 (de) 2008-04-24 2009-10-28 AxoGlia Therapeutics S.A. Chromenonderivate zur Behandlung von neurodegenerativen Krankheiten
US8034838B2 (en) * 2008-05-29 2011-10-11 Daryl Lee Thompson Composition and method for the treatment of neurological disorders
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
CA2748788C (en) 2009-01-05 2021-02-09 Epitogenesis Inc. The use of a composition comprising mustard oil, catechin, and vitamin a for modulating an immune response
GB0906424D0 (en) 2009-04-09 2009-05-20 Antoxis Ltd Use of compounds for differentiation of cells
WO2011029956A1 (en) * 2009-09-14 2011-03-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Flavones and flavanones derivates as dna methyltransferases inhibitors
CN101838252B (zh) * 2010-05-27 2016-05-04 北京德众万全医药科技有限公司 2-正丁基-5-取代氨基苯并呋喃及其制备方法
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
WO2012172090A1 (en) 2011-06-17 2012-12-20 Ludwig Aigner Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders
US10561720B2 (en) 2011-06-24 2020-02-18 EpitoGenesis, Inc. Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
WO2016123141A1 (en) * 2015-01-26 2016-08-04 Berreau Lisa M Carbon monoxide releasing molecules and associated methods
US10123991B2 (en) 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
CN107382941B (zh) * 2017-07-10 2020-05-08 石家庄学院 黄酮衍生物及其制备方法和应用
KR20190022085A (ko) * 2017-08-25 2019-03-06 건국대학교 글로컬산학협력단 타마리세틴을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 약학적 조성물
CN112912371A (zh) 2018-10-03 2021-06-04 豪夫迈·罗氏有限公司 用于治疗和预防乙型肝炎病毒疾病的黄酮衍生物
CA3133199A1 (en) * 2019-03-12 2020-09-17 University Of The Witwatersrand, Johannesburg Compounds having excited state intramolecular proton transfer (esipt) character for use in treating and/or preventing sunburn and/or preventing u.v. damage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
DE69525446T2 (de) * 1994-12-02 2002-10-02 Kao Corp., Tokio/Tokyo Flavanolderivate und haarnährmittel und sie enthaltende wachstumsfördernde zusammensetzung
GB9521184D0 (en) * 1995-10-17 1995-12-20 Univ Strathclyde Flavonoids

Also Published As

Publication number Publication date
EP1534698A1 (de) 2005-06-01
AU2003251328B2 (en) 2010-07-15
DE60316447D1 (de) 2007-10-31
WO2004007475A1 (en) 2004-01-22
US7601754B2 (en) 2009-10-13
US20060137207A1 (en) 2006-06-29
AU2003251328A1 (en) 2004-02-02
CA2492274A1 (en) 2004-01-22
ES2294323T3 (es) 2008-04-01
CA2492274C (en) 2011-06-14
EP1534698B1 (de) 2007-09-19
DE60316447T2 (de) 2008-06-26
WO2004007475A8 (en) 2004-03-18
GB0216371D0 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
DE60316447D1 (de) Flavonoidverbindungen als therapeutische antioxidationsmittel
BRPI0417723A (pt) composição para melhorar a saúde da pele, cabelo e tegumento contendo flavanonas
TW200512007A (en) Cosmetic compositions containing fullerene clusters
GB0022438D0 (en) Organic Compounds
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
ATE508116T1 (de) Ionische uv-a-sonnenschutzmittel und zusammensetzungen, die diese enthalten
PT1140139E (pt) Utilizacao de eritropoietina ou derivados de eritropoietina para o tratamento de isquemia cerebral
TW200716661A (en) A novel triterpenic acid derivative and the skin external preparation containing the same
ATE333263T1 (de) Echinacea-extrakt als antireizendes und alterungsschutzmittel für kosmetika
NZ513096A (en) Compositions for treating inflammatory response
ES2187704T3 (es) Compuestos de indanilideno y su empleo como absorbedor uv.
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
BR0312294A (pt) Arilcarbonil piperazinas e hteroarilcarbonilpiperazinas e o uso das mesmas para tratamento de doenças benignas e malignas
TR200101649T2 (tr) Piperazin türevleri.
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
ATE198467T1 (de) Diaromatische propynyl- oder dienylverbindungen
ATE235885T1 (de) Antioxidative hautpflegemittel
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
KR101656928B1 (ko) 끈끈이여뀌 추출물을 유효성분으로 함유하는 광노화 방지 및 피부주름개선을 위한 조성물
TWI691340B (zh) 一種具抗老化、美白、抗過敏及細胞修護之紅藜萃取物
ATE492530T1 (de) Derivate einer arylsulfonamidosubstituierten hydroxamsäure als matrixmetalloproteinaseinhibitoren
GB0012795D0 (en) Organic compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1534698

Country of ref document: EP